A landmark Judgment in Australia has given new impetus to a group of women in the UK whose vaginal mesh implants have led to them suffering from a range of symptoms including womb prolapse, incontinence and nerve damage.
Sitting in the Federal Court of Australia Judge Anna Katzmann found that much of the information provided by the implant manufacturers, Johnson & Johnson, was inaccurate and that the company failed to warn patients of the associated risks.
This Judgment follows a multi-million pound class action in the United States where Johnson & Johnson have agreed to pay over £90 million to resolve similar claims.
In the UK recipients of mesh implants are awaiting the outcome of the review by Baroness Cumberlege into both pelvic mesh implants and sodium valproate - a drug used to treat epilepsy which, it is claimed, has led to conditions including autism and ADHD in children born to women taking the drug.
The most recent information from Baroness Cumberlege is that her report will be published in late February/early March 2020.
Fosters currently act for many potential Claimants in both the mesh implant and valproate group actions. If you have been affected by either please e-mail us on PI@fosters-solicitors.co.uk or ring us on Freephone 0800 731 8539 for a "no cost" initial chat.